Group One Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,875,200
Closed -$18.9M 7949
2025
Q1
$18.9M Buy
3,875,200
+23,500
+0.6% +$141K 0.05% 343
2024
Q4
$32.1M Buy
3,851,700
+3,848,980
+141,507% +$33.6M 0.07% 231
2024
Q3
$28.3K Sell
2,720
-6,285
-70% -$104K ﹤0.01% 5033
2024
Q2
$177K Sell
9,005
-2,250
-20% -$45.1K ﹤0.01% 3502
2024
Q1
$288K Sell
11,255
-53,790
-83% -$1.38M ﹤0.01% 3245
2023
Q4
$1.8M Buy
65,045
+47,405
+269% +$2.89M ﹤0.01% 1963
2023
Q3
$1.07M Buy
17,640
+3,260
+23% +$229K ﹤0.01% 2195
2023
Q2
$946K Buy
14,380
+1,955
+16% +$143K ﹤0.01% 2410
2023
Q1
$790K Sell
12,425
-2,325
-16% -$266K ﹤0.01% 2339
2022
Q4
$2.04M Buy
14,750
+4,010
+37% +$565K ﹤0.01% 1797
2022
Q3
$1.36M Buy
10,740
+7,205
+204% +$815K ﹤0.01% 2257
2022
Q2
$293K Buy
3,535
+2,420
+217% +$188K ﹤0.01% 3928
2022
Q1
$108K Sell
1,115
-6,275
-85% -$828K ﹤0.01% 5413
2021
Q4
$1.48M Buy
7,390
+2,048
+38% +$483K ﹤0.01% 2933
2021
Q3
$1.32M Sell
5,342
-9,125
-63% -$2.61M ﹤0.01% 3104
2021
Q2
$5.99M Buy
14,467
+5,898
+69% +$2.34M 0.01% 1526
2021
Q1
$3.35M Sell
8,569
-286
-3% -$141K 0.01% 1919
2020
Q4
$4.96M Buy
8,855
+2,911
+49% +$1.84M 0.01% 1283
2020
Q3
$4.15M Sell
5,944
-309
-5% -$241K 0.01% 1037
2020
Q2
$4.94M Sell
6,253
-1,313
-17% -$990K 0.02% 811
2020
Q1
$4.5M Sell
7,566
-4,755
-39% -$4.63M 0.04% 586
2019
Q4
$14M Buy
12,321
+2,640
+27% +$2.87M 0.1% 233
2019
Q3
$11.5M Buy
9,681
+2,555
+36% +$3.9M 0.09% 233
2019
Q2
$11.7M Buy
7,126
+711
+11% +$1.23M 0.11% 199
2019
Q1
$13.1M Sell
6,415
-6,879
-52% -$12.1M 0.15% 128
2018
Q4
$17.1M Buy
13,294
+5,389
+68% +$8.27M 0.15% 126
2018
Q3
$14.9M Sell
7,905
-6,315
-44% -$13M 0.12% 173
2018
Q2
$28.9M Buy
14,220
+11,225
+375% +$25.6M 0.25% 63
2018
Q1
$6.63M Sell
2,995
-7,319
-71% -$18.6M 0.07% 349
2017
Q4
$23.8M Buy
10,314
+4,856
+89% +$9.86M 0.17% 111
2017
Q3
$9.71M Sell
5,458
-1,135
-17% -$1.59M 0.09% 271
2017
Q2
$8.97M Buy
6,593
+4,308
+189% +$5.2M 0.09% 230
2017
Q1
$2.69M Sell
2,285
-1,706
-43% -$1.74M 0.03% 682
2016
Q4
$3.19M Buy
3,991
+1,544
+63% +$1.23M 0.03% 640
2016
Q3
$2.15M Buy
2,447
+448
+22% +$325K 0.02% 810
2016
Q2
$1.12M Buy
1,999
+702
+54% +$398K 0.01% 1186
2016
Q1
$714K Sell
1,297
-594
-31% -$365K 0.01% 1429
2015
Q4
$1.57M Sell
1,891
-108
-5% -$108K 0.02% 1018
2015
Q3
$2.22M Sell
1,999
-2,201
-52% -$4.01M 0.03% 723
2015
Q2
$9.16M Buy
4,200
+2,725
+185% +$5.55M 0.13% 168
2015
Q1
$2.31M Sell
1,475
-571
-28% -$753K 0.04% 569
2014
Q4
$2.43M Buy
2,046
+626
+44% +$418K 0.04% 542
2014
Q3
$660K Buy
1,420
+694
+96% +$320K 0.01% 1411
2014
Q2
$363K Buy
726
+657
+952% +$211K 0.01% 1907
2014
Q1
$20K Buy
+69
New +$20.9K ﹤0.01% 4234

Other funds holding BLUE

Group One Trading's BLUE Position: Q2 2025 in Review

Group One Trading sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 21,693 shares — an estimated $106K sold.

Group One Trading first reported a position in BLUE in Q1 2014 and held it in 39 quarters. The position peaked at $8.62M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Group One Trading reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 21,693 bluebird bio shares in Q2 2025, an estimated $106K.
  • Group One Trading first reported a position in bluebird bio in Q1 2014 and held it in 39 quarters.
  • Group One Trading's bluebird bio position peaked at $8.62M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.